Pathological Yawning in Patients with Acute Middle Cerebral Artery Infarction: Prognostic Significance and Association with the Infarct Location

Pathological Yawning in Patients with Acute Middle Cerebral Artery Infarction: Prognostic Significance and Association with the Infarct Location

Background: Pathological yawning is a compulsive, frequent,repetitive yawning triggered by a specific reason besides fatigue orboredom. It may be related to iatrogenic, neurologic, psychiatric,gastrointestinal, or metabolic disorders. Moreover, it could also beseen in the course of an ischemic stroke.Aims: To determine whether pathological yawning is a prognosticmarker of middle cerebral artery stroke and evaluate its relationshipwith the infarct location.Study Design: Cross-sectional study.Methods: We examined 161 patients with acute middle cerebralartery stroke, consecutively admitted to emergency department.Demographic information, stroke risk factors, stroke type accordingto Trial of Org 10172 in Acute Stroke Treatment classification, bloodoxygen saturation, body temperature, blood pressure, heart rate,glucose levels, daytime of stroke onset, National Institutes of HealthStroke Scale score (National Institutes of Health Stroke Scale score, atadmission and 24 h), modified Rankin scale (at 3 months), and infarctlocations were documented. Pathological yawning was defined as≥3 yawns/15 min. All patients were observed for 6 hours to detectpathological yawning. National Institutes of Health Stroke Scale score>10 was determined as severe stroke. The correlation between thepresence of pathological yawning and stroke severity, infarct location,and the short- and long-term outcomes of the patients were evaluated.Results: Sixty-nine (42.9%) patients had pathological yawning and112 (69.6%) had cortical infarcts. Insular and opercular infarctswere detected in 65 (40.4%) and 54 (33.5%) patients, respectively.Pathological yawning was more frequently observed in patientswith cortical, insular, and opercular infarcts (p

___

  • 1. Writing Group Members, Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, et al. Executive Summary: Heart Disease and Stroke Statistics--2016 Update: A Report From the American Heart Association. Circulation 2016;26;133:447-54.
  • 2. Wolfe CD. The impact of stroke. Br Med Bull 2000;56:275-86.
  • 3. Tur BS, Gursel YK, Yavuzer G, Kucukdeveci A, Arasil T. Rehabilitation outcome of Turkish stroke patients: in a team approach setting. Int J Rehabil Res 2003;26:271-7.
  • 4. Barbizet J. Yawning. J Neurol Neurosurg Psychiatry1958;21:203-9.
  • 5. Guggisberg AG, Mathis J, Schnider A, Hess CW. Why do we yawn? The importance of evidence for specific yawn-induced effects. Neurosci Biobehav Rev 2011;35:1302-4.
  • 6. Krestel H, Bassetti CL, Walusinski O. Yawning- Its anatomy, chemistry, role, and pathological considerations. Prog Neurobiol 2018;161:61-78.
  • 7. Walusinski O. Pathological Yawning, Laughing and Crying. Front Neurol Neurosci 2018;41:40-9.
  • 8. Collins GT, Eguibar JR. Neurophamacology of yawning. Front Neurol Neurosci 2010;28:90-106.
  • 9. Cattaneo L, Cucurachi L, Chierici E, Pavesi G. Pathological yawning as a presenting symptom of brainstem ischaemia in two patients. J Neurol Neurosurg Psychiatry 2006;77:98-100.
  • 10. Thompson SB. The dawn of the yawn: is yawning a warning? Linking neurological disorders. Med Hypotheses 2010;75:630-3.
  • 11. Walusinski O. Yawning in diseases. Eur Neurol 2009;62:180-7.
  • 12. Daquin G, Micallef J, Blin O. Yawning. Sleep Med Rev 2001;5:299-312.
  • 13. Teive HAG, Munhoz RP, Camargo CHF, Walusinski O. Yawning in neurology: a review. Arq Neuropsiquiatria 2018;76:473-80.
  • 14. Postert T, Pöhlau D, Meves S, Nastos I, Przuntek H. Pathological yawning as a symptom of multiple sclerosis. J Neurol 1996;243:300-1.
  • 15. Gallup AC, Gallup GG Jr, Feo C. Yawning, sleep, and symptom relief in patients with multiple sclerosis. Sleep Med 2010;11:329-30.
  • 16. Gallup AC, Eldakar OT. The thermoregulatory theory of yawning: what we know from over 5 years of research. Front Neurosci 2013;6:188.
  • 17. Bauer G, Gerstenbrand F, Hengl W. Involuntary motor phenomena in the locked-in syndrome. J Neurol 1980;223:191-8.
  • 18. Fletcher S, Cohen F, Borenstein F, I Regev, Vardi J. Yawning as a paroxysmal sign of diencephalic seizures. Arch Psychol Psychiatry Neurol 1982;43:45-54.
  • 19. Jacome DE. Compulsive Yawning as Migraine Premonitory Symptom. Cephalalgia 2001;21:623-5.
  • 20. Sandyk R. Excessive yawning and progressive supranuclear palsy. Int J Neurosci 1987;34:123-4.
  • 21. Williams DR. The yawning reflex: an upper motor neuron sign in amyotrophic lateral sclerosis. Neurology 2000;55:1592-3.
  • 22. Wicks P. Excessive yawning is common in the bulbar-onset form of ALS. Acta Psychiatr Scand 2007;116:76.
  • 23. Ghika J, Vingerhoets F, Bogousslavsky J. Dissociated preservation of automaticvoluntary jaw movements in a patient with biopercular and unilateral pontine infarcts. Eur Neurol 2003;50:185-8.
  • 24. Singer OC, Humpich MC, Lanfermann H, Neumann-Haefelin T. Yawning in acute anterior circulation stroke. J Neurol Neurosurg Psychiatry 2007;78:1253-4.
  • 25. Krestel H, Weisstanner C, Hess CW, Bassetti CL, Nirkko A, Wiest R. Insular and caudate lesions release abnormal yawning in stroke patients. Brain Struct Funct 2015;220:803-12.
  • 26. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial: TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
  • 27. Bauer G, Gerstenbrand F, Hengl W. Involuntary motor phenomena in the locked-in syndrome. J Neurol 1980;223:191-8.
  • 28. Argiolas A, Melis MR. The neuropharmacology of yawning. Eur J Pharmacol 1998;343:1-16.
Balkan Medical Journal-Cover
  • ISSN: 2146-3123
  • Başlangıç: 2015
  • Yayıncı: Erkan Mor
Sayıdaki Diğer Makaleler

Incidental Cutaneous Microcystic/Reticular Schwannoma in Pilonidal Sinus

Gülname Fındık GÜVENDİ, Recep BEDİR, Orhan SEMERCİ

Pathological Yawning in Patients with Acute Middle Cerebral Artery Infarction: Prognostic Significance and Association with the Infarct Location

Aslı Aksoy GÜNDOĞDU, Atilla Özcan ÖZDEMİR, Serhat ÖZKAN

Gastrointestinal Involvement in a Patient with Chronic Lymphocytic Leukemia

Yasin YILMAZ, Kazım UYGUN, Ali Erkan DUMAN, Fatih BALLI, Devrim ÇABUK

Superior Thyroid Artery of MLS-preserved Cadavers: A New Microsurgery Training Model

Mehmet Emre YEĞİN, Servet ÇELİK, Okan BİLGE

Acquired Tracheoesophageal Fistula After Esophageal Atresia Repair

Tutku SOYER, Feridun Cahit TANYEL, Özlem Boybeyi TÜRER

Quality-of-life Evaluation of Healthy Siblings of Children with Chronic Illness

Meltem DİNLEYİCİ, Makbule EREN, Figen Şahin DAĞLI, Canan ÖZDEMİR, Koray HARMANCI, Coşkun YARAR, Kürşat Bora ÇARMAN, Aysu Duyan ÇAMURDAN, Enver ŞİMŞEK, Birgül KİREL

Precise and Immediate Action against Predatory Conferences

Zafer KOÇAK

Hypoxic Gene Signature of Primary and Metastatic Melanoma Cell Lines: Focusing on HIF-1β and NDRG-1

Önder BOZDOĞAN, Pınar ATASOY, Mukadder KOÇAK, Nazan BOZDOĞAN, Tarık ÇAVUŞOĞLU, Mustafa Emre ERCİN

Inhibition of Lung Cancer Proliferation by Wogonin is Associated with Activation of Apoptosis and Generation of Reactive Oxygen Species

Chuangcheng CUİ, Chengyang WANG

Retinal and Choroidal Vascular Changes in Eyes with Pseudoexfoliation Syndrome: A Comparative Study Using Optical Coherence Tomography Angiography

Fatih ASLAN, Berna YÜCE, Esat ÇINAR